A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care
Clinical trial NCT03227861 · COMPLETED
Trial details
- NCT number
- NCT03227861
- Sponsor
- Janssen Scientific Affairs, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-31
- Primary completion
- 2019-01-03
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.